Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer

BACKGROUND: Risk of normal tissue toxicity limits the amount of thoracic radiation therapy (RT) that can be routinely prescribed to treat non-small cell lung cancer (NSCLC). An early biomarker of response to thoracic RT may provide a way to predict eventual toxicities—such as radiation pneumonitis—d...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinh, Tru-Khang T., Fendler, Wojciech, Chałubińska-Fendler, Justyna, Acharya, Sanket S., O’Leary, Colin, Deraska, Peter V., D’Andrea, Alan D., Chowdhury, Dipanjan, Kozono, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847218/
https://www.ncbi.nlm.nih.gov/pubmed/27117590
http://dx.doi.org/10.1186/s13014-016-0636-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847218/
https://www.ncbi.nlm.nih.gov/pubmed/27117590
http://dx.doi.org/10.1186/s13014-016-0636-4

Ejemplares similares